David Rhainds

5.6k total citations · 1 hit paper
54 papers, 2.0k citations indexed

About

David Rhainds is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David Rhainds has authored 54 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 25 papers in Molecular Biology and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David Rhainds's work include Lipoproteins and Cardiovascular Health (23 papers), Cholesterol and Lipid Metabolism (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). David Rhainds is often cited by papers focused on Lipoproteins and Cardiovascular Health (23 papers), Cholesterol and Lipid Metabolism (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers). David Rhainds collaborates with scholars based in Canada, United States and France. David Rhainds's co-authors include Louise Brissette, Suzanne Benjannet, Josée Hamelin, Nabil G. Seidah, Nasha Nassoury, Jean‐Claude Tardif, Louise Falstrault, Mathieu R. Brodeur, Daniel J. Rader and Jean‐Claude Tardif and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

David Rhainds

53 papers receiving 1.9k citations

Hit Papers

NARC-1/PCSK9 and Its Natural Mutants 2004 2026 2011 2018 2004 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. NARC-1/PCSK9 and Its Natural Mutants
    2004 532 citations Suzanne Benjannet, David Rhainds et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Rhainds Canada 22 1.2k 621 380 330 300 54 2.0k
Ann Chamberland Canada 15 1.3k 1.1× 515 0.8× 335 0.9× 276 0.8× 254 0.8× 23 1.8k
Reeni B. Hildebrand Netherlands 25 1.2k 1.0× 808 1.3× 372 1.0× 354 1.1× 418 1.4× 41 1.9k
Stephen J. Demosky United States 22 1.0k 0.9× 723 1.2× 330 0.9× 452 1.4× 178 0.6× 37 1.7k
Carmel M. Quinn Australia 24 1.2k 1.0× 1.1k 1.7× 398 1.0× 383 1.2× 422 1.4× 35 2.2k
Louise Brissette Canada 23 931 0.8× 773 1.2× 353 0.9× 252 0.8× 198 0.7× 53 1.8k
Maxime Denis Canada 22 1.4k 1.2× 931 1.5× 285 0.8× 276 0.8× 222 0.7× 27 2.0k
Bart J.M. van Vlijmen Netherlands 26 568 0.5× 661 1.1× 315 0.8× 187 0.6× 482 1.6× 70 2.1k
Marianne Abifadel France 23 1.9k 1.6× 572 0.9× 507 1.3× 425 1.3× 278 0.9× 45 2.4k
Mathilde Varret France 23 1.9k 1.6× 579 0.9× 563 1.5× 509 1.5× 263 0.9× 63 2.5k
Hagai Tavori United States 24 1.2k 1.0× 369 0.6× 270 0.7× 232 0.7× 430 1.4× 47 1.8k

Countries citing papers authored by David Rhainds

Since Specialization
Citations

This map shows the geographic impact of David Rhainds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Rhainds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Rhainds more than expected).

Fields of papers citing papers by David Rhainds

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Rhainds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Rhainds. The network helps show where David Rhainds may publish in the future.

Co-authorship network of co-authors of David Rhainds

This figure shows the co-authorship network connecting the top 25 collaborators of David Rhainds. A scholar is included among the top collaborators of David Rhainds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Rhainds. David Rhainds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barhdadi, Amina, Audrey Lemaçon, Louis‐Philippe Lemieux Perreault, et al.. (2023). Study of effect modifiers of genetically predicted CETP reduction. Genetic Epidemiology. 47(2). 198–212. 1 indexed citations
2.
Brodeur, Mathieu R., David Rhainds, Eric J. Niesor, et al.. (2022). Dalcetrapib and anacetrapib increase apolipoprotein E-containing HDL in rabbits and humans. Journal of Lipid Research. 64(1). 100316–100316. 1 indexed citations
3.
Gélinas, Danielle, Yanfen Shi, Mathieu R. Brodeur, et al.. (2021). ApoA-I mimetic does not improve left ventricular diastolic dysfunction in rabbits without aortic valve stenosis. International Journal of Cardiology. 331. 199–205. 1 indexed citations
4.
Rhainds, David, Mathieu R. Brodeur, & Jean‐Claude Tardif. (2021). Lipoprotein (a): When to Measure and How to Treat?. Current Atherosclerosis Reports. 23(9). 51–51. 21 indexed citations
5.
Gebhard, Cathérine, David Rhainds, Gang He, et al.. (2018). Elevated level of lecithin:cholesterol acyltransferase (LCAT) is associated with reduced coronary atheroma burden. Atherosclerosis. 276. 131–139. 16 indexed citations
6.
Gebhard, Cathérine, Barbara E. Stähli, Yanfen Shi, et al.. (2018). Apolipoprotein A-I proteolysis in aortic valve stenosis: role of cathepsin S. Basic Research in Cardiology. 113(4). 30–30. 14 indexed citations
7.
Dron, Jacqueline S., Jian Wang, Cécile Low‐Kam, et al.. (2017). Polygenic determinants in extremes of high-density lipoprotein cholesterol. Journal of Lipid Research. 58(11). 2162–2170. 47 indexed citations
8.
Brodeur, Mathieu R., David Rhainds, Evelyne Chaput, et al.. (2017). Dalcetrapib and anacetrapib differently impact HDL structure and function in rabbits and monkeys. Journal of Lipid Research. 58(7). 1282–1291. 12 indexed citations
9.
Li, Baoqiang, Cathérine Gebhard, Mathieu R. Brodeur, et al.. (2017). Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo. Atherosclerosis. 258. 8–19. 3 indexed citations
10.
St‐Onge, Geneviève, Nassr Nama, David Rhainds, et al.. (2017). Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3–mediated chemokine scavenging. Journal of Biological Chemistry. 293(3). 893–905. 32 indexed citations
11.
Low‐Kam, Cécile, David Rhainds, Ken Sin Lo, et al.. (2016). Whole-genome sequencing in French Canadians from Quebec. Human Genetics. 135(11). 1213–1221. 13 indexed citations
12.
Bujold, Kim, Karina Furlani Zoccal, David Rhainds, et al.. (2013). EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice. Atherosclerosis. 229(2). 408–414. 19 indexed citations
13.
Bujold, Kim, et al.. (2009). CD36-mediated cholesterol efflux is associated with PPARγ activation via a MAPK-dependent COX-2 pathway in macrophages. Cardiovascular Research. 83(3). 457–464. 49 indexed citations
14.
Benjannet, Suzanne, David Rhainds, Josée Hamelin, Nasha Nassoury, & Nabil G. Seidah. (2006). The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A. Journal of Biological Chemistry. 281(41). 30561–30572. 232 indexed citations
15.
Benjannet, Suzanne, David Rhainds, Rachid Essalmani, et al.. (2004). NARC-1/PCSK9 and Its Natural Mutants. Journal of Biological Chemistry. 279(47). 48865–48875. 532 indexed citations breakdown →
16.
Rhainds, David & Louise Brissette. (2003). The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. The International Journal of Biochemistry & Cell Biology. 36(1). 39–77. 131 indexed citations
17.
Auger, Anick, et al.. (2001). Low and high density lipoprotein metabolism in primary cultures of hepatic cells from normal and apolipoprotein E knockout mice. European Journal of Biochemistry. 268(8). 2322–2330. 13 indexed citations
18.
Rhainds, David, Louise Falstrault, Caroline Tremblay, & Louise Brissette. (1999). Uptake and fate of class B scavenger receptor ligands in HepG2 cells. European Journal of Biochemistry. 261(1). 227–235. 38 indexed citations
19.
Rhainds, David & Louise Brissette. (1999). Low density lipoprotein uptake: holoparticle and cholesteryl ester selective uptake. The International Journal of Biochemistry & Cell Biology. 31(9). 915–931. 25 indexed citations
20.
Rhainds, David, et al.. (1999). Selective uptake of cholesteryl ester from low density lipoprotein is involved in HepG2 cell cholesterol homeostasis. European Journal of Biochemistry. 263(2). 402–409. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann Chamberland Breakdown of academic impact, for papers by Reeni B. Hildebrand Breakdown of academic impact, for papers by Stephen J. Demosky Breakdown of academic impact, for papers by Carmel M. Quinn Breakdown of academic impact, for papers by Louise Brissette Breakdown of academic impact, for papers by Maxime Denis Breakdown of academic impact, for papers by Bart J.M. van Vlijmen Breakdown of academic impact, for papers by Marianne Abifadel Breakdown of academic impact, for papers by Mathilde Varret Breakdown of academic impact, for papers by Hagai Tavori
Rankless by CCL
2026